Tracking records of big price movements since December 14th 2021:
(Scroll LEFT and RIGHT to see full TABLE)
| Date | Sentiment | What Happened? | Last Price On That Closing Day | Price Percentage Changes | Reference |
| Dec 16, 2021 | Positive | Two studies from renowned laboratories in the U.S. and France suggest Adagio's experimental antibody-based drug, ADG20, fights omicron-induced Covid, Jefferies analyst Michael Yee wrote in a report to clients. | $14.18 | +123.31% | LINK |
| Dec 14, 2021 | Negative | Adagio Therapeutics Reports Reduction in In Vitro Neutralizing Activity of ADG20 Against Omicron SARS-CoV-2 Variant | $7.26 | -78.80% | LINK |
